Overview

Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
To determine if FDOPA-PET/MRI imaging can predict response to treatment of bevacizumab.
Phase:
Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Bevacizumab
Camptothecin
Irinotecan